Skip to content
Axcess News – Lifestyle
Author:
Flare Therapeutics Inc.
Flare Therapeutics Appoints New Board Member and CFO/CBO
September 8, 2026
Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officer
June 30, 2026
Flare Therapeutics Announces Three Upcoming Poster Presentations at AACR Annual Meeting 2026
April 6, 2026